- Click here to find the meeting proceedings from last years workshop
- Registration for the HBV Cure workshop is now open. Please click here to register online
Bringing together the experts on HBV Cure research
We are proud to announce the 5th edition of the International HBV Cure Workshop 2018, which will take place on 7 November 2018 in Toronto, Canada. Since 2014, the HBV Cure Workshop is a scientific platform that acts as a catalyst to accelerate the progress for achieving a cure. This meeting will bring together the world’s leading basic, translational and clinical experts to share and discuss the latest research outcomes and challenges.
Introduction from the meeting chairs
This year's International HBV Cure Workshop provides a unique setting for international interchange in order to define the pathway forward for achieving a cure of Hepatitis B. The workshop will gather the world’s leading basic, translational and clinical experts to discuss the challenges they face, as well as research outcomes.
Delegates will have access to the latest developments relating to a cure, a thorough understanding of new research and ongoing clinical trials, and the well-received and highly popular roundtable discussions with the world’s leading experts.
This workshop has been designed for clinicians and researchers with an interest in the development of a cure for the HBV infection.
Do not miss this opportunity to participate in the International HBV Cure Workshop 2018 in Toronto, Canada!
Harry Janssen and Stephen Locarnini,
Meeting Chairs 2018
More than 250 million people are chronically infected with hepatitis B (HBV) around the globe. The purpose of the program is to inform the participants about the developments in the possibilities to find a cure for HBV. The meeting will be highly interactive with input from experts out of the arena of basic, translational and clinical HBV research.
The field of HBV treatment is undergoing major changes and is on the verge of a paradigm shift. The many new treatment options that are becoming available are providing great hopes for decreasing the burden of the disease, simplifying treatment and ultimately curing and eradicating HBV infection.
In order to optimize curative treatment for HBV, outstanding speakers from around the globe will share the newest therapeutic options for viral hepatitis and experts will discuss the path forward to cure this deadly disease, leading to liver cirrhosis and liver cancer. Questions on which end points to use in therapeutic trials and how to combine different agents targeting the virus and/or immune system will be extensively discussed.
This workshop also brings together global inter-disciplinary experts to provide a framework for how academia and industry should could collaborate to achieve the goal of curing hepatitis B.